(1).jpg)
1.png){kind=logo}
Karakteristik Pasien COVID-19 Dengan Hipertensi Di RSUD Dr. Soedarso, Pontianak
Abstract
Hipertensi merupakan penyakit penyerta yang paling sering ditemui pada pasien terkonfirmasi COVID-19 berdasarkan peran dari reseptor ACE2. Hipertensi diketahui berperan pada kejadian komplikasi COVID-19 yang dapat berpengaruh pada tingkat keparahan pasien COVID-19. Penelitian ini bertujuan untuk mengetahui persentase dan karakteristik pasien COVID-19 dengan penyakit penyerta hipertensi di RSUD Dr. Soedarso, Pontianak, menggunakan data sekunder dari rekam medis pasien terkonfirmasi COVID-19 tahun 2021. Penelitian ini menggunakan metode deskriptif observasional dengan desain cross-sectional yang dilaksanakan pada April-Juni 2022, dengan teknik total sampling sebanyak 312 pasien. Data yang diperoleh dianalisis menggunakan bantuan program SPSS Statistics dan Microsoft Excel untuk melihat sebaran data. Dari 2.221 pasien terkonfirmasi COVID-19 yang menjalani perawatan di RSUD Dr. Soedarso, Pontianak terdapat 312 pasien (14%) dengan penyakit penyerta hipertensi, dengan karakteristik, mayoritas pada rentang usia 52-59 tahun atau kategori usia dewasa (57,1%), laki-laki (51%), gejala sedang COVID-19 (63,8%), dengan angka kematin 29,5%. Temuan ini mendukung bukti bahwa pasien COVID-19 dengan hipertensi menunjukkan derajat keparahan yang cenderung lebih tinggi.
Keywords
Full Text:
PDFReferences
Abayomi, A (2021). Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study. Global Health Research and Policy; 6(26):1-8.
Bepouka, B (2022). Mortality associated with COVID-19 and hypertension in sub-Saharan Africa. A systematic review and meta-analysis. J Clin Hypertens; 24:99-105.
Ejaz, H (2020). COVID-19 and comorbidities: Deleterious impact on infected patients. Journal of Infection and Public Health; 13:1833-1839.
Faustine, I (2021). Clinical Characteristics and Severity Profile of COVID-19 Patient with Hypertension in Palu, Central Sulawesi. Indonesian J Pharm; 32(4):563-572.
Garg, S (2020). Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 – COVID-Net, 14 States, March 1-30, 2020. MMWR; 69(15):458-464.
Grasselli, G (2020). Baseline Characteritics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA; 323(16):1574-1581.
Mubarik, S (2021). The Association of Hypertension With the Severity of and Mortality From the COVID-19 in the Early Stage of the Epidemic in Wuhan, China: A Multicenter Retrospective Cohort Study. Frontiers in Medicine; 8:623608.
Pan, W (2020). Clinical Features of COVID-19 in Patients With Essential Hypertension and the Impacts of Renin-angiotensin-aldosterone System Inhibitors on the Prognosis of COVID-19 Patients. Hypertension; 76:732-741.
Paudel, SS (2020). A meta-analysis of 2019 novel corona virus patient clinical characteristics and comorbidities. Research Square. [Online Journal]. Tersedia dari: https://www.researchsquare.com/article/rs-21831/v1.
Pranata, R (2020). Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis and meta-regression. JRASS; 21(2):1470320320926899.
Reyes, C (2021). Characteristics and outcomes of patients with COVID-19 with and without prevalent hypertension: a multinational cohort study. BMJ Open; 11:e057632.
Sanyaolu, A (2020). Comorbidity and its Impact on Patients with COVID-19. SN Comprehensive Clinical Medicine; 2:1069-1076.
Satuan Tugas Penanganan COVID-19 (2021). Peta Sebaran COVID-19. [Internet]. Tersedia dari: https://covid19.go.id/peta-sebaran-covid19.
Savoia, C (2021). Hypertension, a Moving Target in COVID-19. Circulation Research; 128:1062-1079.
Shereen, MA (2020). COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses. Journal of Advanced Research; 24:91-98.
Shibata, S (2020). Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19. Hypertension Research; 31:1-19.
Surendra, H (2021). Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: A hospital-based retrospective cohort study. The Lancet Regional Health-Western Pasific; 9:100108.
Tirtasari, S (2019). Prevalensi dan karakteristik hipertensi pada usia dewasa muda di Indonesia. Tarumanegara Medical Journal; 1(2):395-402.
Vitiello, A (2020). Correlation between renin-angiotensin system and Severe Acute Respiratory Syndrome Coronavirus 2 infection: What do we know? European Journal of Pharmacology; 883:173373.
Wang, D (2020). Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA; 323(11):1061-1096.
Wojciechowska, W (2022). Impact of Arterial Hypertension and Use of Antihypertensive Pharmacotheraphy on Mortality in Patients Hospitalized duet o COVID-19: The CRACoV-HHS Study. Hypertension; 79:2601-2610.
World Health Organization (2021). WHO Coronavirus (COVID-19) Dashboard. [Internet]. Tersedia dari: https://covid19.who.int/.
Ya’qoub, L (2021). Sex and gender differences in COVID-19: More to be learned! American Heart Journal Plus; 3:100011.
Yang, J (2020). Prevalence of comorbidities and its effect in patients infected with SARS-CoV-2: a systematic review and meta-analysis. International Journal of Infectious Diseases; 94:91-95.
Zhong, L (2021). Effects of hypertension on the outcomes of COVID-19: a multicentre retrospective cohort study. Ann Med; 53(1):770-776.
Zhou, F (2020). Clinical course and risk factors for mortality of adults inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet; 395:1054-1062.
DOI: https://doi.org/10.33024/jmm.v9i4.21281
Refbacks
- There are currently no refbacks.
Copyright (c) 2025 Jurnal Medika Malahayati
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
